Skip to content

To study the effect of total intravenous anesthesia before the end of operation on the improvement of recovery quality and postoperative cognitive dysfunction in elderly patients with long-term intravenous-inhalation anesthesia

To study the effect of total intravenous anesthesia before the end of operation on the improvement of recovery quality and postoperative cognitive dysfunction in elderly patients with long-term intravenous-inhalation anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098977
Enrollment
Unknown
Registered
2025-03-17
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia recovery quality and postoperative cognitive dysfunction

Interventions

Propofol group:Sufentanil 0.3-0.5ug/kB, etomidate 0.3-0.5mg/kg, cisatracurium besilate 0.1-0.2mg/kg, and lidocaine 50mg for anesthesia induction. During anesthesia maintenance, sevoflurane and remifen
Sevoflurane group:Sufentanil 0.3-0.5ug/kg, etomidate 0.3-0.5mg/kg, cisatracurium besylate 0.1-0.2mg/kg and lidocaine 50mg for anesthesia induction, and sevoflurane and remifentanil will be used throug

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
66 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age greater than 65 years old; 2. American Society of Anesthesiologists (ASA) Physical Status I-III; 3. Primary school education or above; 4. Negative bell painting test; 5. MMSE score> 23 points; 6. Operation time>3h; 7. Sign the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Age> 85 years; 2. Neurosurgery and cardiac surgery; 3. Patients with a history of neurological diseases, stroke, other significant central nervous system diseases or severe psychiatric diseases, multiple trauma and head trauma, endocrine or metabolic diseases.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart rate;Time to extubation;Quality of Recovery-40 (QoR-40) questionnaire;Mini-Mental State Examination score, MMSE scores;Aldrete recovery score;Length of PACU stay;

Secondary

MeasureTime frame
Ramsay sedation score;Visual Analogue Scale;Cough up;Agitation;Shiver;

Countries

China

Contacts

Public ContactXue Li; Di Zhang

The Second Affiliated Hospital of Harbin Medical University

LX84635616@163.com+86 137 9667 4236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026